New Companies
Filter News
Found 3,244 articles
-
Germany’s pharma giant Merck KGaA and Silicon Valley data analytics company Palantir Technologies are forming a joint venture called Syntropy. Syntropy will be based in Boston and will focus on cancer data analytics tools.
-
Statera Spine Announces Company Formation
11/19/2018
Statera Spine, Inc. (Statera), a privately held software-enabled healthcare diagnostics company focused on spine imaging analytics, announced today the formation of the company as a subsidiary of Ortho Kinematics, Inc.
-
RXi Pharmaceuticals Corporation Changes Name to Phio Pharmaceuticals Corp.
11/19/2018
Reflects Company's Transition to Develop Groundbreaking Immuno-Oncology Therapeutics
-
The Ott Group Announces the Creation of Ethos Biosciences, Inc.
11/19/2018
New subsidiary acquires Exocell product line from Glycadia Pharmaceuticals
-
In announcing the round, Camel-IDS said the finances will be used for a phase Ib/II trial of its lead program CAM-H2, a treatment option in HER2-positive cancers, while further developing preclinical programs and broadening the pipeline.
-
Open Now, No Appointment Necessary: Melrose, Massachusetts' Only Medical Marijuana Dispensary, Garden Remedies' Second Location
11/16/2018
This morning, Garden Remedies opened its doors to serve patients in Melrose, Massachusetts' only medical marijuana dispensary, located at 732 Newburyport Turnpike, Melrose, Massachusetts, 02176.
-
ASH Establishes ASH Research Collaborative to Accelerate Progress in Hematology
11/15/2018
ASH RC now requesting proposals from research sites interested in new sickle cell clinical trials network
-
Every year, Forbes creates a list of 30 Under 30, people under the age of 30 who have made a mark and show promise in various areas. They just came out with the 2019 30 Under 30: Healthcare. Here we highlight a dozen of the winners for their roles in biopharma-related endeavors.
-
F1 Oncology's International Affiliate, EXUMA Biotechnology, Announces Acquisition Of Strategic CAR-T Assets
11/13/2018
F1 Oncology, Inc., today announced that its international affiliate, EXUMA Biotechnology Hong Kong, has formed Shanghai EXUMA Biotechnology Co., Ltd., a wholly foreign-owned enterprise (WFOE), to acquire all rights to novel chimeric antigen receptor T (CAR-T) cell therapy and manufacturing assets in Shanghai and Shenzhen
-
Cabaletta Bio launched out of the University of Pennsylvania with an exclusive license deal and two multi-year sponsored research agreements. The fledgling biotech company will work on engineered T cell products for B cell-mediated autoimmune disease.
-
Gail Maderis, currently president and chief executive officer of South San Francisco-based Antiva Biosciences, has a rock-solid resume.
-
One of the biggest areas of research when it comes to cancer is prediction, because the sooner cancer is detected, the higher the chance that the patient will survive. In most cases, cancer is diagnosed after it has already entered into the advanced stages, which severely decreases the effectiven...
-
IQ BAR Launches in Boston to Target Paleo - Vegan - Keto Health Food Market
11/8/2018
A new company, IQ BAR, a Health Bar, recently launched in 2017 and in 2018 became the most crowd-funded bar company in history, selling $90,000 worth of product.
-
Ascendis Pharma Announces Formation of VISEN Pharmaceuticals to Develop and Commercialize TransCon™ Endocrinology Rare Disease Therapies in China
11/8/2018
50/50 joint venture with investor syndicate led by Vivo Capital
-
Three Boston-area developers, King Street Properties, Mugar Enterprises and the DiStefano family, have proposed a possible new life sciences campus in the area to compete with Kendall Square. It is a 607,900-square-foot campus on a 4.3-acre site in Allston, an officially recognized neighborhood o...
-
Updated: Mirum Pharmaceuticals Launches With Phase III-Ready Drug From Shire, $120 Million in Fin...
11/7/2018
Based in San Diego, Mirum entered into the agreement with Shire for the exclusive global rights to develop and market maralixibat, a Phase II oral inhibitor of the apical sodium-dependent bile acid transporter (ASBT). -
LifeScan Unveils New Name and Branding for the LifeScan Diabetes Institute
11/7/2018
Previously the Johnson & Johnson Diabetes Institute; Remains Committed to Transforming Diabetes Care through World-Class Experiential Learning
-
Elo Life Systems Launches Australian Subsidiary in Queensland
11/5/2018
Elo Life Systems has opened a new Australian location at the Queensland University of Technology (QUT), Gardens Point Campus in Brisbane.
-
Pharmatech Associates Launches International Contracting and Services Company in Doha Qatar to Build Next-Generation Life Science Facilities Worldwide
11/4/2018
At the ISPE annual meeting today, Pharmatech Associates introduced Pharmatech Associates International Contracting and Services, LLC (PAICS), a new company with headquarters in Doha, Qatar.
-
North American Cannabis Holdings Inc Executes AmeriCanna Cafe Spinoff and Announces Planned Dividend
11/1/2018
The spinoff is part of a comprehensive strategy to support the AmeriCanna Cafe in expanding and commercializing its cannabis themed restaurant concept.